trending Market Intelligence /marketintelligence/en/news-insights/trending/n-7jmnb80e1cisiypodupg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Pacific Biosciences plans common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Pacific Biosciences plans common stock offering

Pacific Biosciences of California Inc. is planning a public offering of its common shares.

The Menlo Park, Calif.-based company intends to grant the underwriters an option to buy up to an additional 15% of the shares sold in the offering.

Pacific Biosciences intends to use the net proceeds from the offering for general corporate purposes, including capital expenditures and working capital. It may also use part of the proceeds to acquire or invest in complementary businesses and technologies.

Cowen and Co. LLC and Cantor Fitzgerald & Co. are acting as the joint book-running managers for the offering.

Pacific Biosciences is a life sciences company that develops sequencing systems to help scientists resolve genetically complex problems.